What is Pfizer's expected EPS for Q2 2026?

Analysts expect Pfizer (PFE) to report consensus EPS of approximately $0.68 for Q2 2026. Estimates range from $0.61 to $0.76.

What revenue do analysts expect for Pfizer in Q2 2026?

The consensus revenue forecast for Pfizer (PFE) in Q2 2026 is approximately $14.4B. Forecasts range from $14B to $14.7B.

How many analysts cover Pfizer?

11 analysts contribute to the Pfizer (PFE) Q2 2026 consensus estimate.

Has Pfizer beaten earnings estimates recently?

Pfizer beat analyst EPS estimates in 2 of the last 2 quarters. Pfizer beat revenue estimates in 2 of 2. In the most recent quarter (Q1 2026), Pfizer EPS beat by 3.9% and revenue beat by 4.4%.

When does Pfizer report Q2 2026 earnings?

Pfizer (PFE) is expected to report Q2 2026 earnings on August 4, 2026 before market open.

PFE Q2 2026 earnings estimate

Consensus EPS · Q2 2026

$0.68

Consensus revenue · Q2 2026

$14.4B

Analysts

Expected report

Aug 4, 2026

Before open

Upcoming earnings

Locks in 11 days 13 hours · BMO: Locks 8:00 PM ET previous day

Revenue$14.4B$14B – $14.7B

EPS$0.68$0.61 – $0.76

What to watch

Analyst ratings: Downgrades trending

Make your prediction

Analyst consensus

Based on estimates from 11 analysts.

Metric	Low	Consensus	High
Revenue	$14B	$14.4B	$14.7B
EPS	$0.61	$0.68	$0.76
EBITDA	$4.2B	$4.3B	$4.3B
EBIT	$3B	$3.1B	$3.1B
Net income	$3.8B	$3.9B	$3.9B

Revenue$14.4B
EPS$0.68
EBITDA$4.3B
EBIT$3.1B
Net income$3.9B

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

Period	Rev. actual	Rev. est.	Rev. surprise	EPS actual	EPS est.	EPS surprise
Q1 2026	$14.5B	$13.8B	+4.4%	$0.75	$0.72	+3.9%
Q4 2025	$17.6B	$16.8B	+4.2%	$0.66	$0.57	+16.4%

Q1 2026+4.4%+3.9%
Q4 2025+4.2%+16.4%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Grade A — Strong upward revisions

Metric	Now	30d ago	60d ago	90d ago	30d Δ
Revenue	$14.4B	$14.4B	—	—	-0.1%
EPS	$0.68	$0.68	—	—	+0.0%

1 revised up (30d)1 revised down (30d)

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for Pfizer (PFE) Q2 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 1 analyst.

Low: $25.00
Consensus: $26.89
Median: $27.00
High: $30.00
Current: $24.82
Upside: +8.3%

Upside calculated vs most recent trading price of $24.82.

Analyst ratings

Consensus: Hold — based on 39 analyst ratings.

Buy 15Hold 23Sell 1

24-month trend

Recent analyst actions

Date	Firm	Action	From	To
Jul 13, 2026	Guggenheim	maintain	Buy	Buy
Jul 13, 2026	BMO Capital	maintain	Outperform	Outperform
Jul 10, 2026	B of A Securities	maintain	Neutral	Neutral
Jul 8, 2026	JP Morgan	maintain	Neutral	Neutral
Jul 6, 2026	HSBC	downgrade	Buy	Hold
Jul 6, 2026	Cantor Fitzgerald	maintain	Neutral	Neutral
Jun 10, 2026	RBC Capital	upgrade	Underperform	Sector Perform
Apr 29, 2026	Citigroup	maintain	Neutral	Neutral
Apr 20, 2026	RBC Capital	maintain	Underperform	Underperform
Apr 13, 2026	UBS	maintain	Neutral	Neutral

Jul 13, 2026GuggenheimBuy
Jul 13, 2026BMO CapitalOutperform
Jul 10, 2026B of A SecuritiesNeutral
Jul 8, 2026JP MorganNeutral
Jul 6, 2026HSBCHold
Jul 6, 2026Cantor FitzgeraldNeutral
Jun 10, 2026RBC CapitalSector Perform
Apr 29, 2026CitigroupNeutral
Apr 20, 2026RBC CapitalUnderperform
Apr 13, 2026UBSNeutral

Frequently asked questions

Pfizer (PFE) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

PFE Overview

Counters

Income Statement

Cash Flow

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation